Cellectar Biosciences Inc. Series A Warrants
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $15,290,349.
Profit Margin
| 2011 | 44.47K | -7.43M | -16716.7% |
|---|---|---|---|
| 2012 | 44.47K | -7.43M | -16716.7% |
| 2013 | 0 | -10.78M | |
| 2014 | 0 | -8.05M | |
| 2015 | 0 | -5.49M | |
| 2016 | 0 | -6.18M | |
| 2017 | 0 | -13.56M | |
| 2018 | 0 | -13.23M | |
| 2019 | 0 | -14.09M | |
| 2020 | 0 | -15.09M |
CLRBZ Income Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44.47K | 44.47K |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44.47K | 44.47K |
Operating exp. | ||||||||||
Research and development | 10.14M | 8.99M | 6.83M | 9.46M | 4.75M | 5.15M | 5.96M | 6.86M | 3.59M | 3.59M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 15.29M | 14.22M | 11.68M | 13.61M | 9.45M | 8.55M | 9.22M | 11.29M | 6.60M | 6.60M |
Operating income | -15.29M | -14.17M | -13.33M | -13.60M | -9.44M | -8.75M | -9.89M | -12.40M | -7.03M | -7.03M |
Other income (expenses), net | 196.17K | 85.71K | 91.73K | 38.68K | 3.26M | 3.26M | 1.83M | 1.61M | 708.59K | 397.70K |
Income before tax | -15.09M | -14.09M | -13.23M | -13.56M | -6.18M | -5.49M | -8.05M | -10.78M | -6.32M | -7.43M |
Income tax expense | 196.17K | 85.71K | 91.73K | 38.68K | 3.26M | 3.26M | 1.83M | 1.61M | 1.10M | 0 |
Net income | -15.09M | -14.09M | -13.23M | -13.56M | -6.18M | -5.49M | -8.05M | -10.78M | -7.43M | -7.43M |
Earnings per share | ||||||||||
Basic EPS | -1.3 | -1.84 | -4.47 | -0.97 | -1.36 | -7.03 | -1.75 | -0.19 | -0.31 | -0.31 |
Diluted EPS | -1.3 | -1.84 | -4.47 | -0.97 | -1.36 | -7.03 | -1.75 | -0.19 | -0.31 | -0.31 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |